市場調查報告書
商品編碼
1439491
全球氣管插管市場:洞察、競爭格局、市場預測:2030 年Endotracheal Tubes - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
2023年全球氣管插管市場規模為15.3億美元。預計到 2030 年,該市場將達到 19.5 億美元,2024 年至 2030 年的預測期間複合年增長率為 4.12%。呼吸系統疾病盛行率上升、創傷病例增加、各種癌症盛行率上升以及產品開發技術進步等因素預計將推動氣管插管市場的發展。
推動氣管插管市場的關鍵因素之一是,由於道路事故導致的病例數量不斷增加,對氣管插管的需求不斷增長。根據世界衛生組織 (WHO) 道路交通傷害說明書 (2023),全世界每年有近 130 萬人因道路交通傷害死亡。情況說明書進一步指出,每年有 2,000 萬至 5,000 萬人遭受非致命傷害,這可能導致需要採取廣泛的救生幹預措施來改善患者的治療結果。嚴重的車禍會導致腦損傷和無法維持呼吸,因此透過插管進行呼吸支持極為重要。此外,進行手術時使用麻醉會減少呼吸機制中涉及的反射。透過氣管插管進行呼吸支持是加護病房醫療照護的重要組成部分。因此,在預測期內,交通事故數量的增加以及其他創傷原因預計將支持氣管插管市場的成長。
該報告研究了全球氣管插管市場,提供了市場概述,以及按產品類型、袖帶類型、插管路線、年齡層、最終用戶、地區和參與市場的公司概況等劃分的趨勢。
Endotracheal Tubes Market By Product Type (Standard, Reinforced, Coated, Others), By Cuff Type (Cuffed And Uncuffed/Cuffless), By Intubation Route (Nasal, Oral, And Others), By Age Group (Adult And Pediatric), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to increase in anesthesia administration during surgeries due to trauma surgeries and mechanical ventilation due to respiratory distress.
Global endotracheal tubes market was valued at USD 1.53 billion in 2023, growing at a CAGR of 4.12% during the forecast period from 2024 to 2030 to reach USD 1.95 billion by 2030. Factors such as the growing prevalence of respiratory disorders, rising number of trauma cases, the increasing prevalence of various cancers, and technological advancements in product development among other factors are expected to drive the endotracheal tubes market.
Endotracheal Tubes Market Dynamics:
One of the key aspects driving the endotracheal tubes market is the growing demand for endotracheal tubes due to increase in the number of cases due to road accidents. According to the factsheet by the World Health Organization (WHO) on Road traffic injuries (2023), near about 1.3 million people lost their lives as a result of road injuries across the globe each year. The factsheet further stated that every year, between 20 and 50 million people suffer from non-fatal injuries which may result in the performance of major lifesaving procedures in order to improve outcomes for patients. Severe road accidents may result in brain damage and may leave patients incapacitated to sustain breathing thereby making respiratory support through intubation extremely crucial. Furthermore, administration of anesthesia for conducting surgery reduces reflexes involved in respiratory mechanism. Respiratory support through intubation by endotracheal tubes form a crucial part of medical in the intensive care units. Therefore, the rising incidents of road accidents among other causes of trauma injuries are expected to aid in the growth of the endotracheal tubes market during the forecast period.
Furthermore, another key contributor in the growing demand for endotracheal tubes is the increasing prevalence of various cancers. As per the data provided by the GLOBOCAN study 2020 by the International Agency for Research on Cancer, in 2020, an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths were reported. Cancer treatments involve chemotherapy, radiation treatment, or hematopoietic stem cell transplant (HCT) among others and may often result in immunosuppression. Cancer patients often suffer from respiratory insufficiency due as a result of these treatments thereby making acute respiratory failure a common complaint among patients with malignancies. Such patients are then treated with invasive and noninvasive ventilation where in endotracheal tubes are employed. Therefore, the rising prevalence of cancers are expected to drive the growth of the endotracheal tubes market during the forecast period.
Additionally, many drug-coated endotracheal tubes are in clinical development such as ISurTec Endotracheal tubes which would help in the prevention of ventilator-assisted pneumonia cases in intubated patients is further expected to drive the demand for endotracheal tubes in coming years.
However, complications associated with the placement of endotracheal tubes as well as mechanical failure of endotracheal tubes, along with increased chances of ventilator-assisted pneumonia in intubated patients may prove to be certain restraints to the endotracheal tubes market growth.
Contrary to other medical specialties, the endotracheal tubes market maintained a steady pace in revenue generation even during the implementation of lockdowns measures to curb the spread of the COVID-19 infection. For instance, the American Association for Bronchology and Interventional Pulmonology recommended performing open surgical tracheostomy (OST) or percutaneous dilatational tracheostomy in case of respiratory failure in COVID patients. This pandemic paved way for emergency product approvals including endotracheal tubes. For instance, a U.S.-based biotech firm, N8, secured emergency use authorization from Health Canada For its CeraSheild Endotracheal Tubes in mechanically ventilated COVID-19 patients. Nevertheless, the market for endotracheal tubes remained majorly undeterred by the pandemic as endotracheal intubation is an emergency procedure and those were being catered to even during the lockdown, and with the resumption of economic activities across the globe, the future outlook for the endotracheal tubes market appears positive during the forecast period.
Endotracheal Tubes Market Segment Analysis:
Endotracheal Tubes Market by Product Type (Standard, Reinforced, Coated, and Others), by Cuff Type (Cuffed and Uncuffed/Cuffless), by Intubation Route (Nasal, Oral, and Others), by Age Group (Adult and Pediatric), by End User (Hospitals, Ambulatory Surgical Centers, and Others), by Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the cuff type segment of the endotracheal tubes market, the cuffed endotracheal tubes category is expected to account for the significant market share during the forecast period. This can be ascribed to advantages associated with these devices such as providing a seal within the airway, allowing airflow through the endotracheal tube but preventing passage of air or fluids around the tube. Other advantages associated with cuffed endotracheal tubes such as greater ease of intubation, lower rate and better control of flow of anesthetic gases, better control of air leakage, and decreased risk of aspiration and infection also make them a popular among end users. Therefore, the demand for cuffed endotracheal tubes is estimated to grow during the forecast period.
North America is expected to dominate the Overall Endotracheal Tubes Market:
Among all the regions, North America is expected to account for the significant market share in the orthopedic prosthetics market. North America is estimated to account for the dominant market share because of the increasing prevalence of respiratory diseases such as chronic obstructive pulmonary disease, high number of traumatic brain injury, increasing prevalence of respiratory disorders, increasing volume of surgical procedures as well as high awareness among people regarding disease management and among other factors in the region.
One of the key factors supporting the growth of the North American endotracheal tubes market is the high number of traumatic brain injury in the North American countries, particularly the United States. As per the data provided by the Centers for Disease Control and Prevention (2023), about 166 deaths from traumatic brain injury (TBI) are reported in the country. In 2019, near about 61,000 TBI-related deaths were reported in the country as stated by the above-mentioned source. Brain-injured patients with altered consciousness frequently require intubation and invasive mechanical ventilation to protect the airways from aspiration and to prevent harmful secondary insults wherein endotracheal tubes are employed. Thus, the growing number of traumatic brain injuries in the country may result in increased use of mechanical ventilation ultimately driving the product demand in the United States endotracheal tubes market.
Additionally, another key factor influencing the demand for endotracheal tubes is the increasing prevalence of various respiratory disorders such as chronic obstructive pulmonary disease (COPD) in the region. For instance, as per the Office of Disease Prevention and Health Promotion, United States (2023), about 14.8 million people are affected with COPD in the country in the present scenario. Even though not all cases of COPD present with severe symptoms, considering the presence of large patient pool, patients with COPD-associated exacerbations also make up a huge part of the population. In severe COPD cases, there can be upper and lower airway obstructions which are treated with endotracheal intubation where in endotracheal tubes are used. Therefore, the rising prevalence of various respiratory disorders wherein endotracheal intubation is unavoidable may result in an increase in product demand in the country as well as the region, thereby driving the regional growth of the endotracheal tubes market.
Furthermore, the prompt and well-established healthcare services and infrastructure further contributes to the growth of the regional endotracheal tubes market growth. Moreover, the presence of key players in the region and supportive reimbursement programs further provide immense growth opportunities for endotracheal tubes market.
Endotracheal Tubes Market Key Players:
Some of the key market players operating in the endotracheal tubes market includes Medtronic, Smiths Medical, Teleflex Incorporated, VYAIRE MEDICAL, INC., Avanos Medical, Inc, ConvaTec, Inc., BACTIGUARD AB, Vygon, N8 Medical, LLC, Novo Klinik-Service GmbH, Intersurgical Ltd, Salter Labs (SunMed), Angiplast Pvt Ltd., Guangzhou Orcl Medical Co.,Ltd, ROYAX, S.R.O, Sumi, HUM Gesellschaft fur Homecare und Medizintechnik mbH, MEDADV Medical, Van Oostveen Medical B.V., DEAS S.R.L and others.
Recent Developmental Activities in Endotracheal Tubes Market:
In November 2020, Brian Medical Inc received the 510k product approval from the US Food and Drug Administration for their Tenax Laser Resistant Endotracheal Tube.
In April 2020, Hydromer partnered with N8 Medical to become the exclusive coating supplier as well as manufacturing partner for the latter's CeraShield(TM) Endotracheal Tube.
Key Takeaways from the Endotracheal Tubes Market Report Study
Market analysis for current endotracheal tubes market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the endotracheal tubes market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the global endotracheal tubes market.
Various opportunities available for the other competitor in the endotracheal tubes market space.
What are the top performing segments in 2023? How these segments will perform in 2030.
Which is the top-performing regions and countries in the current endotracheal tubes market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for endotracheal tubes market growth in the coming future?
Target Audience who can be benefited from this Endotracheal Tubes Market Report Study
Endotracheal Tubes products providers
Research organizations and consulting companies
Endotracheal Tubes-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in endotracheal tubes
Various End-users who want to know more about the endotracheal tubes market and latest technological developments in the endotracheal tubes market.
Frequently Asked Questions for Endotracheal Tubes Market:
An endotracheal tube is a flexible plastic tube that is placed through the mouth into the trachea (windpipe) to help a patient breathe which is employed in mechanical ventilation.
Global endotracheal tubes market was valued at USD 1.53 billion in 2023, growing at a CAGR of 4.12% during the forecast period from 2024 to 2030 to reach USD 1.95 billion by 2030.
Factors such as the growing prevalence of respiratory disorders, rising number of trauma cases, the increasing prevalence of various cancers, and technological advancements in product development among other factors are expected to drive the endotracheal tubes market.
Some of the key market players operating in the endotracheal tubes market includes Medtronic, Smiths Medical, Teleflex Incorporated, VYAIRE MEDICAL, INC., Avanos Medical, Inc, ConvaTec, Inc., BACTIGUARD AB, Vygon, N8 Medical, LLC, Novo Klinik-Service GmbH, Intersurgical Ltd, Salter Labs (SunMed), Angiplast Pvt Ltd., Guangzhou Orcl Medical Co.,Ltd, ROYAX, S.R.O, Sumi, HUM Gesellschaft fur Homecare und Medizintechnik mbH, MEDADV Medical, Van Oostveen Medical B.V., DEAS S.R.L and others.
North America is estimated to account for the dominant market share because of the increasing prevalence of respiratory diseases such as chronic obstructive pulmonary disease, high number of traumatic brain injury, increasing prevalence of respiratory disorders, increasing volume of surgical procedures as well as high awareness among people regarding disease management and among other factors in the region.